Background: Chronic obstructive pulmonary disease (COPD) is a type of chronic respiratory disease. Studies confirmed that ferroptosis was involved in the progression of COPD, and its related mechanism is not clear. The aim of this study was to identify ferroptosis-related genes and reveal its pathological application in COPD.
Methods: First, we downloaded two datasets from the Gene Expression Omnibus (GEO) to obtain the differential genes of COPD. Ferroptosis-related genes were obtained from the ferroptosis database, FerrDb. Next, we obtained the key genes in COPD rat to identify potential biomarkers using quantitative real-time polymerase chain reaction. Ferroptosis and inflammation were assessed using hematoxylin and eosin staining, lung function tests, and transmission electron microscopy (TEM).
Results: These results were used to construct a COPD risk model with six key genes and explore the immunological characteristics of these genes. The resulting molecular subtype construction confirmed the importance of the key genes in COPD. Furthermore, we proved that ferroptosis occurred in the COPD rat model and identified the six key genes in rat lung tissue. TEM showed significant functional impairment and structural alterations in mitochondria, which is the key site of ferroptosis.
Conclusion: Our COPD risk model, incorporating six key genes, highlighted their immunological roles in COPD using bioinformatics analysis and in vivo experiments. We hope to provide the basis for the treatment targeting ferroptosis in COPD.
| [1] |
Anllo H, Larue F, Herer B. Anxiety and depression in chronic obstructive pulmonary disease: perspectives on the use of hypnosis. Front Psychol. 2022; 13:913406.
|
| [2] |
Alfahad AJ, Alzaydi MM, Aldossary AM, et al. Current views in chronic obstructive pulmonary disease pathogenesis and management. Saudi Pharm J. 2021; 29(12): 1361-1373.
|
| [3] |
Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017; 389(10082): 1931-1940.
|
| [4] |
Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017; 171(2): 273-285.
|
| [5] |
Gao M, Monian P, Pan Q, Zhang W, Xiang J, Jiang X. Ferroptosis is an autophagic cell death process. Cell Res. 2016; 26(9): 1021-1032.
|
| [6] |
Yang Y, Ma Y, Li Q, et al. STAT6 inhibits ferroptosis and alleviates acute lung injury via regulating P53/SLC7A11 pathway. Cell Death Dis. 2022; 13(6):530.
|
| [7] |
Zeng Z, Huang H, Zhang J, et al. HDM induce airway epithelial cell ferroptosis and promote inflammation by activating ferritinophagy in asthma. FASEB J. 2022; 36(6):e22359.
|
| [8] |
Yoshida M, Minagawa S, Araya J, et al. Involvement of cigarette smoke-induced epithelial cell ferroptosis in COPD pathogenesis. Nat Commun. 2019; 10(1):3145.
|
| [9] |
Davis S, Meltzer PS. GEOquery: a bridge between the gene expression omnibus (GEO) and BioConductor. Bioinformatics. 2007; 23(14): 1846-1847.
|
| [10] |
Ezzie ME, Crawford M, Cho JH, et al. Gene expression networks in COPD: microRNA and mRNA regulation. Thorax. 2012; 67(2): 122-131.
|
| [11] |
Kim WJ, Lim JH, Lee JS, Lee SD, Kim JH, Oh YM. Comprehensive analysis of transcriptome sequencing data in the lung tissues of COPD subjects. Int J Genomics. 2015; 2015:206937.
|
| [12] |
Vishweswaraiah S, George L, Purushothaman N, Ganguly K. A candidate gene identification strategy utilizing mouse to human big-data mining: “3R-tenet” in COPD genetic research. Respir Res. 2018; 19(1):92.
|
| [13] |
Jeong I, Lim JH, Oh DK, Kim WJ, Oh YM. Gene expression profile of human lung in a relatively early stage of COPD with emphysema. Int J Chron Obstruct Pulmon Dis. 2018; 13: 2643-2655.
|
| [14] |
Zhou N, Bao J. FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations. Database (Oxford). 2020; 2020:baaa021.
|
| [15] |
Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015; 43(7):e47.
|
| [16] |
Zhang H, Meltzer P, Davis S. RCircos: an R package for Circos 2D track plots. BMC Bioinform. 2013; 14:244.
|
| [17] |
Luo W, Brouwer C. Pathview: an R/Bioconductor package for pathway-based data integration and visualization. Bioinformatics. 2013; 29(14): 1830-1831.
|
| [18] |
Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015; 1(6): 417-425.
|
| [19] |
Engebretsen S, Bohlin J. Statistical predictions with glmnet. Clin Epigenetics. 2019; 11(1):123.
|
| [20] |
Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008; 9:559.
|
| [21] |
Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014; 42(Database issue): D92-D97.
|
| [22] |
Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11): 2498-2504.
|
| [23] |
Warde-Farley D, Donaldson SL, Comes O, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010; 38(Web Server issue): W214-W220.
|
| [24] |
Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010; 26(12): 1572-1573.
|
| [25] |
Nguyen T, Sherratt PJ, Pickett CB. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol. 2003; 43: 233-260.
|
| [26] |
Zhang Z, Fu C, Liu J, et al. Hypermethylation of the Nrf2 promoter induces Ferroptosis by inhibiting the Nrf2-GPX4 Axis in COPD. Int J Chron Obstruct Pulmon Dis. 2021; 16: 3347-3362.
|
| [27] |
Jiang J, Zheng Z, Chen S, et al. Hypoxia inducible factor (HIF) 3alpha prevents COPD by inhibiting alveolar epithelial cell ferroptosis via the HIF-3alpha-GPx4 axis. Theranostics. 2024; 14(14): 5512-5527.
|
| [28] |
Wang Y, Xia S. Relationship between ACSL4-mediated ferroptosis and chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2023; 18: 99-111.
|
| [29] |
Doll S, Proneth B, Tyurina YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017; 13(1): 91-98.
|
| [30] |
D'Herde K, Krysko DV. Ferroptosis: oxidized PEs trigger death. Nat Chem Biol. 2017; 13(1): 4-5.
|
| [31] |
Xie J, Liu M, Gao Y, et al. Integration of metabolomics and network pharmacology to reveal the protective mechanism underlying Qibai Pingfei capsule on chronic obstructive pulmonary disease. Front Pharmacol. 2023; 14:1258138.
|
| [32] |
Tang X, Li Z, Yu Z, et al. Effect of curcumin on lung epithelial injury and ferroptosis induced by cigarette smoke. Hum Exp Toxicol. 2021; 40(12_suppl): S753-S762.
|
| [33] |
Norheim KL, Ben Ezra M, Heckenbach I, et al. Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial. Nat Aging. 2024; 4(12): 1772-1781.
|
| [34] |
Huang Q, Wang Y, Zhang L, et al. Single-cell transcriptomics highlights immunological dysregulations of monocytes in the pathobiology of COPD. Respir Res. 2022; 23(1):367.
|
| [35] |
Zhang YH, Hoopmann MR, Castaldi PJ, et al. Lung proteomic biomarkers associated with chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2021; 321(6): L1119-L1130.
|
| [36] |
Yuan J, Li X, Fang N, et al. Perilla leaf extract (PLE) attenuates COPD airway inflammation via the TLR4/Syk/PKC/NF-kappaB pathway in vivo and in vitro. Front Pharmacol. 2021; 12:763624.
|
| [37] |
Grainge CL, Davies DE. Epithelial injury and repair in airways diseases. Chest. 2013; 144(6): 1906-1912.
|
| [38] |
Calissi G, Lam EW, Link W. Therapeutic strategies targeting FOXO transcription factors. Nat Rev Drug Discov. 2021; 20(1): 21-38.
|
| [39] |
Zhong S, Chen W, Wang B, et al. Energy stress modulation of AMPK/FoxO3 signaling inhibits mitochondria-associated ferroptosis. Redox Biol. 2023; 63:102760.
|
| [40] |
Ding Y, Wu Q. 1,25D/VDR inhibits pancreatic beta cell ferroptosis by downregulating FOXO1 expression in diabetes mellitus. Cell Signal. 2023; 105:110564.
|
| [41] |
McGeachy MJ, Cua DJ, Gaffen SL. The IL-17 family of cytokines in health and disease. Immunity. 2019; 50(4): 892-906.
|
| [42] |
Ritzmann F, Lunding LP, Bals R, Wegmann M, Beisswenger C. IL-17 cytokines and chronic lung diseases. Cells. 2022; 11(14):2132.
|
| [43] |
Roos AB, Sethi S, Nikota J, et al. IL-17A and the promotion of neutrophilia in acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015; 192(4): 428-437.
|
| [44] |
Song J, Zhang H, Tong Y, et al. Molecular mechanism of interleukin-17A regulating airway epithelial cell ferroptosis based on allergic asthma airway inflammation. Redox Biol. 2023; 68:102970.
|
| [45] |
Ren JX, Li C, Yan XL, Qu Y, Yang Y, Guo ZN. Crosstalk between oxidative stress and Ferroptosis/Oxytosis in ischemic stroke: possible targets and molecular mechanisms. Oxid Med Cell Longev. 2021; 2021:6643382.
|
| [46] |
Wang J, Al-Majid D, Brenner JC, Smith JD. Mutant HRas signaling and rationale for use of farnesyltransferase inhibitors in head and neck squamous cell carcinoma. Target Oncol. 2023; 18(5): 643-655.
|
| [47] |
Bartolacci C, Andreani C, El-Gammal Y, Scaglioni PP. Lipid metabolism regulates oxidative stress and Ferroptosis in RAS-driven cancers: a perspective on cancer progression and therapy. Front Mol Biosci. 2021; 8:706650.
|
| [48] |
Schott C, Graab U, Cuvelier N, Hahn H, Fulda S. Oncogenic RAS mutants confer resistance of RMS13 rhabdomyosarcoma cells to oxidative stress-induced ferroptotic cell death. Front Oncol. 2015; 5:131.
|
| [49] |
Bai W, Huo S, Li J, Shao J. Advances in the study of the ubiquitin-editing enzyme A20. Front Pharmacol. 2022; 13:845262.
|
| [50] |
Gao C, Xiao F, Zhang L, et al. SENP1 inhibition suppresses the growth of lung cancer cells through activation of A20-mediated ferroptosis. Ann Transl Med. 2022; 10(4):224.
|
| [51] |
Xiong D, Geng C, Zeng L, et al. Artesunate induces ferroptosis by regulating MT1G and has an additive effect with doxorubicin in diffuse large B-cell lymphoma cells. Heliyon. 2024; 10(7):e28584.
|
| [52] |
Gong CW, Yuan MM, Qiu BQ, et al. Identification and validation of Ferroptosis-related biomarkers in septic cardiomyopathy via bioinformatics analysis. Front Genet. 2022; 13:827559.
|
| [53] |
Bialkowska AB, Yang VW, Mallipattu SK. Kruppel-like factors in mammalian stem cells and development. Development. 2017; 144(5): 737-754.
|
| [54] |
Lu Y, Qin H, Jiang B, et al. KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma. Cancer Lett. 2021; 522: 1-13.
|
| [55] |
Tabnak P, HajiEsmailPoor Z, Soraneh S. Ferroptosis in lung cancer: from molecular mechanisms to prognostic and therapeutic opportunities. Front Oncol. 2021; 11:792827.
|
| [56] |
Song W, Craft J. T follicular helper cell heterogeneity: time, space, and function. Immunol Rev. 2019; 288(1): 85-96.
|
| [57] |
Qin K, Xu B, Pang M, Wang H, Yu B. The functions of CD4 T-helper lymphocytes in chronic obstructive pulmonary disease. Acta Biochim Biophys Sin Shanghai. 2022; 54(2): 173-178.
|
| [58] |
Iborra S, Soto M, Stark-Aroeira L, et al. H-ras and N-ras are dispensable for T-cell development and activation but critical for protective Th1 immunity. Blood. 2011; 117(19): 5102-5111.
|
| [59] |
Vallath S, Hynds RE, Succony L, Janes SM, Giangreco A. Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities. Eur Respir J. 2014; 44(2): 513-522.
|
| [60] |
Ryu MH, Yun JH, Morrow JD, et al. Blood gene expression and immune cell subtypes associated with chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med. 2023; 208(3): 247-255.
|
| [61] |
Rabacal W, Pabbisetty SK, Hoek KL, et al. Transcription factor KLF2 regulates homeostatic NK cell proliferation and survival. Proc Natl Acad Sci U S A. 2016; 113(19): 5370-5375.
|
| [62] |
Ham J, Kim J, Ko YG, Kim HY. The dynamic contribution of neutrophils in the chronic respiratory diseases. Allergy Asthma Immunol Res. 2022; 14(4): 361-378.
|
| [63] |
Huang Y, Niu Y, Wang X, Li X, He Y, Liu X. Identification of novel biomarkers related to neutrophilic inflammation in COPD. Front Immunol. 2024; 15:1410158.
|
| [64] |
Li H, Yang Y, Yang Y, et al. Multiomics was used to clarify the mechanism by which air pollutants affect chronic obstructive pulmonary disease: a human cohort study. Toxicology. 2024; 501:153709.
|
| [65] |
Wang F, Barrero CA. Multi-omics analysis identified drug repurposing targets for chronic obstructive pulmonary disease. Int J Mol Sci. 2024; 25:20.
|
| [66] |
Wang Z, Zhao Y, Zhang L. Emerging trends and hot topics in the application of multi-omics in drug discovery: a bibliometric and visualized study. Curr Pharm Anal. 2024; 21(1): 20-32.
|
RIGHTS & PERMISSIONS
2025 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.
PDF
(24824KB)
